Overview

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Ropinirole has shown to improve mood in depressed patients as well as to improve the symptoms of Restless Legs Syndrome. Up to 40% of RLS patients suffer from mild depression, therefore it would be important for decisions no therapy to know whether a drug could improve both depressive and RLS symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole